AUBELPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AUBELPHARMA
Largest movements
- Cash +€76,420
up €76,420 (+35.9%), from €213,155 to €289,576
mainly Net result for the year (+€103,467) and Other debts (+€62,650)
- Tangible fixed assets -€26,787
down €26,787 (-13.3%), from €201,442 to €174,655
of which Land and buildings: -€20,726
- Stocks and contracts -€23,668
down €23,668 (-14.0%), from €169,373 to €145,704
- Receivables within one year +€12,801
up €12,801 (+17.3%), from €74,034 to €86,835
of which Other amounts receivable: +€6,410
- Other debts +€62,650
up €62,650 (+23.6%), from €264,977 to €327,627
- Debts after one year -€25,162
down €25,162 (-12.5%), from €200,888 to €175,727
- Taxes -€7,747
down €7,747 (-38.8%), from €19,986 to €12,239
- Staff costs +€6,129
up €6,129 (+11.3%), from €54,237 to €60,366
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €658,376 | €696,844 | +€38,468 | +5.8% |
| Fixed assets | 21/28 | €201,442 | €174,655 | -€26,787 | -13.3% |
| Tangible fixed assets | 22/27 | €201,442 | €174,655 | -€26,787 | -13.3% |
| Land and buildings | 22 | €182,782 | €162,056 | -€20,726 | -11.3% |
| Plant, machinery and equipment | 23 | €17,317 | €12,598 | -€4,719 | -27.2% |
| Furniture and vehicles | 24 | €1,343 | €0 | -€1,343 | -100% |
| Current assets | 29/58 | €456,934 | €522,189 | +€65,255 | +14.3% |
| Stocks and contracts in progress | 3 | €169,373 | €145,704 | -€23,668 | -14.0% |
| Stocks | 30/36 | €169,373 | €145,704 | -€23,668 | -14.0% |
| Amounts receivable within one year | 40/41 | €74,034 | €86,835 | +€12,801 | +17.3% |
| Trade receivables | 40 | €69,146 | €75,537 | +€6,391 | +9.2% |
| Other amounts receivable | 41 | €4,888 | €11,298 | +€6,410 | +131% |
| Cash at bank and in hand | 54/58 | €213,155 | €289,576 | +€76,420 | +35.9% |
| Deferred charges and accrued income | 490/1 | €372 | €73 | -€298 | -80.2% |
| Total equity and liabilities | 10/49 | €658,376 | €696,844 | +€38,468 | +5.8% |
| Equity | 10/15 | €110,499 | €110,565 | +€67 | +0.1% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €48,499 | €48,565 | +€67 | +0.1% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Distributable reserves | 133 | €42,299 | €42,365 | +€67 | +0.2% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €547,877 | €586,278 | +€38,401 | +7.0% |
| Amounts payable after more than one year | 17 | €200,888 | €175,727 | -€25,162 | -12.5% |
| Financial debts | 170/4 | €200,888 | €175,727 | -€25,162 | -12.5% |
| Amounts payable within one year | 42/48 | €335,377 | €393,510 | +€58,133 | +17.3% |
| Current portion of amounts payable after more than one year | 42 | €24,425 | €25,162 | +€736 | +3.0% |
| Trade debts | 44 | €34,482 | €30,921 | -€3,561 | -10.3% |
| Suppliers | 440/4 | €34,482 | €30,921 | -€3,561 | -10.3% |
| Taxes, remuneration and social security | 45 | €11,492 | €9,799 | -€1,693 | -14.7% |
| Taxes | 450/3 | €2,665 | €384 | -€2,281 | -85.6% |
| Remuneration and social security | 454/9 | €8,827 | €9,416 | +€588 | +6.7% |
| Other amounts payable | 47/48 | €264,977 | €327,627 | +€62,650 | +23.6% |
| Accrued charges and deferred income | 492/3 | €11,612 | €17,042 | +€5,430 | +46.8% |
| Remuneration, social security and pensions | 62 | €54,237 | €60,366 | +€6,129 | +11.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €27,034 | €26,787 | -€247 | -0.9% |
| Other operating charges | 640/8 | €2,630 | €2,756 | +€126 | +4.8% |
| Gross operating margin | 9900 | €218,553 | €216,455 | -€2,098 | -1.0% |
| Operating profit (loss) | 9901 | €134,653 | €126,546 | -€8,106 | -6.0% |
| Financial income | 75/76B | €66 | €96 | +€30 | +45.4% |
| Recurring financial income | 75 | €66 | €96 | +€30 | +45.4% |
| Financial charges | 65/66B | €11,460 | €10,936 | -€524 | -4.6% |
| Recurring financial charges | 65 | €11,460 | €10,936 | -€524 | -4.6% |
| Profit (loss) for the period before taxes | 9903 | €123,259 | €115,706 | -€7,553 | -6.1% |
| Income taxes | 67/77 | €19,986 | €12,239 | -€7,747 | -38.8% |
| Profit (loss) for the period | 9904 | €103,272 | €103,467 | +€195 | +0.2% |
| Profit (loss) for the period to be appropriated | 9905 | €103,272 | €103,467 | +€195 | +0.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.